Epidrugs: targeting epigenetic marks in cancer treatment

Article Properties
  • Language
    English
  • DOI (url)
    10.1080/15592294.2019.1640546
  • Publication Date
    2019/07/13
  • Journal
    Epigenetics
  • Indian UGC (journal)
  • Refrences
    118
  • Citations
    154
  • Cristiana Libardi Miranda Furtado Department of Surgery, Drug Research and Development Center, Federal University of Ceara, Fortaleza, Brazil
  • Maria Claudia Dos Santos Luciano Department of Physiology and Pharmacology, Drug Research and Development Center, Federal University of Ceara, Fortaleza, Brazil
  • Renan Da Silva Santos Department of Physiology and Pharmacology, Drug Research and Development Center, Federal University of Ceara, Fortaleza, Brazil
  • Gilvan Pessoa Furtado Department of Biotechnology, Oswaldo Cruz Foundation, Fortaleza, Brazil
  • Manoel Odorico Moraes Department of Surgery, Drug Research and Development Center, Federal University of Ceara, Fortaleza, BrazilDepartment of Physiology and Pharmacology, Drug Research and Development Center, Federal University of Ceara, Fortaleza, Brazil
  • Claudia Pessoa Department of Physiology and Pharmacology, Drug Research and Development Center, Federal University of Ceara, Fortaleza, Brazil
Cite
Miranda Furtado, Cristiana Libardi, et al. “Epidrugs: Targeting Epigenetic Marks in Cancer Treatment”. Epigenetics, vol. 14, no. 12, 2019, pp. 1164-76, https://doi.org/10.1080/15592294.2019.1640546.
Miranda Furtado, C. L., Dos Santos Luciano, M. C., Silva Santos, R. D., Furtado, G. P., Moraes, M. O., & Pessoa, C. (2019). Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics, 14(12), 1164-1176. https://doi.org/10.1080/15592294.2019.1640546
Miranda Furtado CL, Dos Santos Luciano MC, Silva Santos RD, Furtado GP, Moraes MO, Pessoa C. Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics. 2019;14(12):1164-76.
Journal Categories
Science
Biology (General)
Science
Biology (General)
Genetics
Refrences
Title Journal Journal Categories Citations Publication Date
Title 2018
Title 2017
Title 2014
Title PLOS ONE
  • Medicine
  • Science
  • Science: Science (General)
 2012
Title 2012
Citations
Title Journal Journal Categories Citations Publication Date
USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination

 Journal of Cancer Research and Clinical Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 2024
Construction of methylation driver gene-related prognostic signature and development of a new prognostic stratification strategy in neuroblastoma Genes & Genomics
  • Science: Biology (General)
  • Technology: Chemical technology: Biotechnology
  • Science: Biology (General): Genetics
  • Science: Biology (General): Genetics
 2024
Recent advances in anti-tumor therapeutic approaches for the universally active transcriptional factor c-MYC Proceedings of the Indian National Science Academy
  • Science: Science (General)
 2024
Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia Ageing Research Reviews
  • Science: Biology (General): Cytology
  • Medicine: Internal medicine: Special situations and conditions: Geriatrics
  • Medicine: Medicine (General)
 2024
Targeting ‘histone mark’: Advanced approaches in epigenetic regulation of telomere dynamics in cancer Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Physics
  • Science: Biology (General): Genetics
 2024
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)64
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens44
Science: Biology (General)37
Science: Biology (General): Genetics31
Medicine: Therapeutics. Pharmacology27
Medicine: Public aspects of medicine: Toxicology. Poisons18
Science: Chemistry15
Science: Biology (General): Cytology15
Science: Chemistry: Organic chemistry: Biochemistry14
Medicine12
Science: Chemistry: General. Including alchemy10
Technology: Chemical technology: Biotechnology8
Science: Chemistry: Analytical chemistry5
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology5
Science: Microbiology4
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy4
Science: Science (General)4
Science: Physics4
Medicine: Pathology4
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs3
Science: Mathematics: Instruments and machines: Electronic computers. Computer science3
Science3
Medicine: Internal medicine3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system2
Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases2
Medicine: Medicine (General): Computer applications to medicine. Medical informatics2
Medicine: Ophthalmology2
Medicine: Pharmacy and materia medica2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system1
Medicine: Internal medicine: Infectious and parasitic diseases1
Technology: Mechanical engineering and machinery1
Science: Mathematics: Instruments and machines1
Science: Mathematics1
Science: Mathematics: Probabilities. Mathematical statistics1
Medicine: Medicine (General): Medical technology1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry1
Technology: Environmental technology. Sanitary engineering1
Science: Biology (General): Ecology1
Science: Chemistry: Organic chemistry1
Medicine: Surgery1
Medicine: Gynecology and obstetrics1
Science: Biology (General): Reproduction1
Medicine: Internal medicine: Special situations and conditions: Geriatrics1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry: Therapeutics. Psychotherapy1
Medicine: Other systems of medicine1
The category Medicine: Medicine (General) 64 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy and was published in 2020. The most recent citation comes from a 2024 study titled PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer. This article reached its peak citation in 2023, with 51 citations. It has been cited in 105 different journals, 37% of which are open access. Among related journals, the Cancers cited this research the most, with 8 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year